Crystallographic and spectroscopic study on a known orally active progestin
Patrizia Ferraboschi1, Pierangela Ciuffreda2, Samuele Ciceri1
1Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Via Saldini 50, 20133 Milano, Italy.
Medrogestone, a known progestational steroid, was analyzed using X-ray and NMR spectroscopy. This study provides detailed crystallographic and spectroscopic data, filling gaps in the scientific literature.
Area of Science:
- Steroid chemistry
- Crystallography
- Nuclear Magnetic Resonance (NMR) spectroscopy
Background:
- Medrogestone (6,17α-Dimethyl-4,6-pregnadiene-3,20-dione) is a steroid with established progestational activity.
- Existing literature lacks comprehensive crystallographic and NMR spectroscopic data for medrogestone.
Purpose of the Study:
- To elucidate the crystallographic and NMR spectroscopic properties of medrogestone.
- To address the existing literature gap regarding medrogestone's structural and conformational characteristics.
- To fully assign (1)H and (13)C NMR signals for medrogestone and its synthetic intermediates.
Main Methods:
- Medrogestone synthesis using a traditional procedure.
- Comprehensive (1)H and (13)C Nuclear Magnetic Resonance (NMR) spectroscopy.
- X-ray diffraction analysis for structural and stereochemical characterization.
Main Results:
- Complete assignment of (1)H and (13)C NMR signals for medrogestone and its synthetic precursors.
- Detailed structural and stereochemical information obtained through X-ray analysis of medrogestone and 17α-methyl-3-ethoxy-pregna-3,5-dien-20-one.
- In-depth conformational analysis enabled by the crystallographic data.
Conclusions:
- The study successfully characterized medrogestone and its precursor, providing valuable crystallographic and NMR data.
- The comprehensive spectroscopic assignments and structural analyses deepen the understanding of medrogestone's properties.
- This research contributes essential data to the scientific literature on medrogestone and related steroids.
More Related Videos
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
09:19Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization
Published on: March 16, 2020
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prochirality
Intrauterine Drug Delivery Systems
